Coloplast A/S (LON: 0QBO)
London
· Delayed Price · Currency is GBP · Price in DKK
824.10
+9.43 (1.16%)
At close: Jan 22, 2025
Coloplast Revenue
In the fiscal year ending September 30, 2024, Coloplast had annual revenue of 27.03B DKK with 10.33% growth. Coloplast had revenue of 6.95B in the quarter ending September 30, 2024, with 11.68% growth.
Revenue
27.03B DKK
Revenue Growth
+10.33%
P/S Ratio
n/a
Revenue / Employee
1.62M DKK
Employees
16,639
Market Cap
20.93B GBP
Revenue Chart
* This company reports financials in DKK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 27.03B | 2.53B | 10.33% |
Sep 30, 2023 | 24.50B | 1.92B | 8.51% |
Sep 30, 2022 | 22.58B | 3.15B | 16.23% |
Sep 30, 2021 | 19.43B | 882.00M | 4.76% |
Sep 30, 2020 | 18.54B | 605.00M | 3.37% |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 30, 2016 | Pro | Pro | Pro |
Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shell | 221.41B |
AstraZeneca | 38.20B |
HSBC Holdings | 43.25B |
Unilever | 51.12B |
Rio Tinto Group | 42.87B |
RELX PLC | 9.30B |
BP p.l.c. | 144.69B |
British American Tobacco p.l.c. | 26.18B |